FIELD: biotechnology.
SUBSTANCE: present invention relates to tetraspanin-based fusion proteins, in which the extracellular loop is completely or partially replaced by peptide sequences of different composition, and can be used for their production and use as a carrier. Fused protein consists of a first domain (i), a second domain (ii) located between the first and third domains, and a third domain (iii), flexible linkers and, optionally, a terminal fourth and/or fifth domain. Domain (i) consists of the following domains of tetraspanin: transmembrane domain 1 (TM1), a small extracellular loop (SEL), transmembrane domain 2 (TM2), small intracellular loop (SIL) and transmembrane domain 3 (TM3). Domain (ii) consists of a peptide of less than 100 kDa with a given amino acid sequence, wherein domain (ii) has an amino acid sequence, which is identical to less than 70 % along the entire length in relation to LEL tetraspanin. Domain (iii) consists of transmembrane domain 4 (TM4) of tetraspanin.
EFFECT: invention enables presenting a peptide with a given amino acid sequence on the surface of a mammalian cell.
19 cl, 10 dwg, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) FOR CANCER TREATMENT | 2019 |
|
RU2811466C2 |
IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
FULLY HUMAN MESOTHELIN ANTIBODIES AND IMMUNE EFFECTOR CELLS TARGETING MESOTHELIN | 2016 |
|
RU2748281C2 |
GLYPICAN-3 ANTIBODY AND USE THEREOF | 2016 |
|
RU2744245C2 |
PD-L1 ANTIBODIES BINDING DOG PD-L1 | 2015 |
|
RU2722562C2 |
DOG ANTIBODIES WITH MODIFIED CH-CH SEQUENCES | 2014 |
|
RU2815059C2 |
MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
DOG ANTIBODIES WITH MODIFIED CH2-CH3 SEQUENCES | 2014 |
|
RU2801209C2 |
ENVELOPED VIRUS RESISTANT TO INACTIVATION WITH COMPLEMENT FOR TREATMENT OF MALIGNANT NEOPLASMS | 2018 |
|
RU2791051C2 |
Authors
Dates
2020-12-28—Published
2016-03-04—Filed